InvestorsHub Logo
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
QUEEN2 Free
04/24/24 11:46 AM
profile icon
Ringing 7 Free
04/24/24 11:35 AM
profile icon
JCESOSA Free
04/24/24 11:32 AM
profile icon
JCESOSA Free
04/24/24 11:12 AM
profile icon
Hugie Free
04/24/24 6:19 AM
profile icon
Ringing 7 Free
04/23/24 5:14 PM
profile icon
Ringing 7 Free
04/23/24 2:49 PM
profile icon
Eddo1976 Free
04/23/24 11:57 AM
profile icon
JCESOSA Free
04/23/24 10:58 AM
profile icon
DEMDOTS Free
04/22/24 3:42 PM
profile icon
oceans11 Free
04/22/24 2:42 PM
profile icon
jjch Free
04/22/24 2:33 PM
profile icon
JCESOSA Free
04/22/24 1:31 PM
profile icon
JCESOSA Free
04/22/24 9:51 AM
profile icon
Livi1 Free
04/22/24 12:12 AM
profile icon
Ringing 7 Free
04/21/24 11:36 AM
profile icon
thesmallguy Free
04/21/24 10:03 AM
profile icon
Hugie Free
04/21/24 9:32 AM
profile icon
trader59 PremiumMember
04/20/24 10:33 PM
profile icon
BeeHaus2 PremiumMember
04/20/24 11:16 AM
Bullish
Bullish
profile icon
KingKnight24 Free
04/20/24 12:40 AM
profile icon
trader59 PremiumMember
04/19/24 10:49 PM
profile icon
jjch Free
04/19/24 10:35 PM
profile icon
trader59 PremiumMember
04/19/24 7:15 PM
profile icon
Hugie Free
04/19/24 5:24 PM
profile icon
Hugie Free
04/19/24 5:21 PM
profile icon
JCESOSA Free
04/19/24 3:33 PM
profile icon
trader59 PremiumMember
04/19/24 3:31 PM
profile icon
billdean8 Free
04/19/24 3:28 PM
profile icon
trader59 PremiumMember
04/19/24 2:15 PM
profile icon
billdean8 Free
04/19/24 1:10 PM
profile icon
trader59 PremiumMember
04/19/24 1:01 PM
profile icon
billdean8 Free
04/19/24 12:58 PM
profile icon
Eddo1976 Free
04/19/24 12:24 PM
profile icon
Hugie Free
04/19/24 12:01 PM
profile icon
JCESOSA Free
04/19/24 11:44 AM
profile icon
trader59 PremiumMember
04/19/24 11:39 AM

Strategic Asset Leasing Inc (fka LEAS) RSS Feed

Followers
900
Posters
Posts (Today)
0
Posts (Total)
155603
Created
10/19/07
Type
Free
Moderators

ANew Medical Inc.

Symbol: LEAS



$LEAS Summary DD (True Value .057/Share):

$LEAS is merging with $RWOD (Nasdaq, $10/share).

$LEAS has approved (Europe) drugs for anti-aging, etc ... Website: https://www.anewmeds.com/
Now they want to get FDA approval for the US.

$LEAS Shares will be converted to $RWOD Shares.

175 $LEAS Shares will become 1 $RWOD Share.

175 x .057 = $10.

So the True Value is .057/share.

All this info came from the 8K that $RWOD filed: https://www.sec.gov/ix?doc=/Archives/edgar/data/1907223/000121390023045945/ea179544-8k_redwoods.htm

Here is the Calculation using the info from the 8K:

"be converted into the right to receive a number of shares of Redwoods Common Stock equal to the Merger Consideration."

“Merger Consideration” means with respect to each outstanding share of Company Common Stock a number of shares of Redwoods Common Stock equal to the Exchange Ratio (and with an aggregate value equal to the Closing Equity Value), allocated to the Company Stockholders as set forth on the Allocation Schedule.

“Exchange Ratio” means (a) the Closing Equity Value Per Share, divided by (b) the Redwoods Share Value.

== .057 / 10 == .0057

“Closing Equity Value Per Share” means (a) the Closing Equity Value, divided by (b) the Fully Diluted Company Capitalization.

== $60M / 1045M = .057

“Closing Equity Value” means $60,000,000.

“Fully Diluted Company Capitalization” means, without duplication, the sum of the aggregate number of shares of Company Common Stock outstanding as of immediately prior to the Effective Time, determined on an as-converted basis (including, for the avoidance of doubt, the number of shares of Company Common Stock issuable upon conversion of any outstanding convertible securities of the Company).

== Outstanding = 1045M

“Redwoods Share Value” means $10.00.

Exchange Ratio for 1 Share:

1 Share of RWOD / .0057 = 175. SO 175 LEAS shares will convert to 1 share of RWOD.

175 Shares currently is worth 175 x .0022 = .385. So .385 current value converts to $10. == 26 Bagger.

$10 / 175 = .057/Share == TRUE Value of $LEAS Shares.


Here are the values at different price points:

.0022 = 26 Bagger
.0050 = 11 Bagger
.01 = 6 Bagger
.02 = 3 Bagger

And investors that hold shares through the Merger will realize .057/Share conversion value

....................Currently working on this...................................
ANEW MEDICAL, INC. has acquired pharmaceutical and biotechnology assets in the medical oncology, biologics, and gene therapy sectors of the pharmaceutical and biotechnology industry. The company is considering several financing vehicles.

Medical product development and commercialization. The Company recently acquired five generic oncology drugs approved and manufactured in Germany and they plan to gain approval for these drugs in the US in 2023. The Company is preparing for a pivotal Phase 3 study of an anti-cancer antibody product that is highly similar to Genentech/Roche's brand name Avastin (bevacizumab), the Company has licensed a needle-free jet injector for drug delivery, and the Company is in the pre-clinical stages of development of a gene therapy product candidate based on the delivery of a human alpha-Klotho gene and protein to prevent and/or treat neurodegenerative diseases such as Alzheimer's and Lou Gehrig's disease (ALS). Other product candidates will stem from these platform technologies of pharmaceuticals, biologics, and gene therapy.

 

The Company's medical R&D facilities are in the U.S. (near the University of Nebraska Medical Center, Omaha, Nebraska) and in Barcelona, Spain (Autonomous Universitat de Barcelona). Each R&D facility is comprised of over 4,000 sq ft of R&D and office space, currently leased and equipped with research equipment, incubators, tissue culture facilities for production of plasmid DNA, HEPA-filtered hoods for aseptic handling, and testing equipment (PCR, spectrophotometers, microscopes, etc). The generic oncology drugs are manufactured in Germany. With future funding, the Company plans to acquire or build a GMP manufacturing facility to supply novel plasmid DNA ("transgenes") to be used in gene therapy programs, to provide contract manufacturing revenue, and for commercial product manufacturing.

 
 

 
Board Info
Posts Today
0
Posts (Total)
155603
Posters
Moderators
New Post